PDB Short entry for 4W2F
HEADER    RIBOSOME/ANTIBIOTIC                     2014-09-12  XXXX              
AUTHOR    Y.S.POLIKANOV, I.A.OSTERMAN, T.SZAL, V.N.TASHLITSKY,                  
AUTHOR   2 M.V.SEREBRYAKOVA, P.KUSOCHEK, D.BULKLEY, I.A.MALANICHEVA,            
AUTHOR   3 T.A.EFIMENKO, O.V.EFREMENKOVA, A.L.KONEVEGA, K.J.SHAW, A.A.BOGDANOV, 
AUTHOR   4 M.V.RODNINA, O.A.DONTSOVA, A.S.MANKIN, T.A.STEITZ, P.V.SERGIEV       
JRNL        AUTH   Y.S.Polikanov, I.A.Osterman, T.Szal, V.N.Tashlitsky,         
JRNL        AUTH 2 M.V.Serebryakova, P.Kusochek, D.Bulkley, I.A.Malanicheva,    
JRNL        AUTH 3 T.A.Efimenko, O.V.Efremenkova, A.L.Konevega, K.J.Shaw,       
JRNL        AUTH 4 A.A.Bogdanov, M.V.Rodnina, O.A.Dontsova, A.S.Mankin,         
JRNL        AUTH 5 T.A.Steitz, P.V.Sergiev                                      
JRNL        TITL   Amicoumacin a inhibits translation by stabilizing mRNA       
JRNL        TITL 2 interaction with the ribosome.                               
JRNL        REF    Mol.Cell                      V.  56   531 2014              
JRNL        REFN        MOCEFL  US      1097-2765                               
JRNL        PMID   25306919                                                     
JRNL        DOI    10.1016/j.molcel.2014.09.020                                 
CRYST1  210.060  448.570  623.950  90.00  90.00  90.00 P 21 21 21   16          
SCALE1      0.004761  0.000000  0.000000        0.00000                         
SCALE2      0.000000  0.002229  0.000000        0.00000                         
SCALE3      0.000000  0.000000  0.001603        0.00000